Gifts to Physicians from the Pharmaceutical Industry: An Ethical Analysis

Annals of Emergency Medicine

Volumn 48, Issue 5, 2006, Pages 513-521

  Marco, Catherine A ^a   Moskop, John C ^b   Solomon, Robert C ^c,d   Geiderman, Joel M ^e,f,g   Larkin, Gregory L ^h  

^a ST VINCENT MERCY MEDICAL CENTER   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c Ohio Valley Medical Center   (United States)

^d WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE   (United States)

^e Department of Emergency Medicine ^*  (United States)

^f BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^g CEDARS SINAI MEDICAL CENTER   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADMINISTRATIVE PERSONNEL; ARTICLE; CLINICAL RESEARCH; DECISION MAKING; DEONTOLOGY; DRUG INDUSTRY; EMERGENCY PHYSICIAN; EMPLOYMENT; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE POLICY; INCOME; INFORMATION DISSEMINATION; MEDICAL ETHICS; MEDICAL SOCIETY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROFESSIONAL STANDARD; RISK ASSESSMENT; TRUST;

CONFLICT OF INTEREST; DECISION MAKING; DRUG INDUSTRY; EDUCATION, MEDICAL; ETHICAL ANALYSIS; FINANCIAL SUPPORT; GIFT GIVING; HUMANS; PHYSICIANS; PROFESSIONAL PRACTICE; UNITED STATES;

EID: 33750050588     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2005.12.013     Document Type: Article

References (70)

1. Accreditation Council on Continuing Medical Education. Principles to guide the relationship between graduate medical education and industry. Available at: http://www.acgme.org/acWebsite/positionPapers/pp_GMEGuide.pdf. Accessed January 1, 2005.
2. IMS Health. Global pharmaceutical sales, 1997-2004 [IMS Health Incorporated Web site]. Available at: http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_71234024_ 71234033,00.html. Accessed July 30, 2005.
3. Kaiser Family Foundation. Trends in promotional spending for prescription drugs, 1996-2003. Available at: http://www.kff.org/insurance/7031/ti2004-1-20.cfm. Accessed August 16, 2005.
4. Goldman D.P., Joyce G.F., Escarce J.J., et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 291 (2004) 2344-2350
5. Brichacek A., and Sellers L.J. Flexing their budgets: big pharma spend trends. Pharmaceutical Executive (2001) 78-86 (September)
6. Reeder M., Dougherty J., and White L.J. Pharmaceutical representatives and emergency medicine residencies: a national survey. Ann Emerg Med. 22 (1993) 1593-1596
7. Sigworth S.K., Nettleman M.D., and Cohen G.M. Pharmaceutical branding of resident physicians. JAMA 286 (2001) 1024-1025
8. Marco C.A. Pharmaceutical advertising in emergency departments. Acad Emerg Med. 11 (2004) 401-404
9. Sierles F.S., Brodkey A.C., Clearly L.M., et al. Medical students' exposure to and attitudes about drug company interactions: a national survey. JAMA 294 (2005) 1034-1042
10. Steinman M.A., Shlipak M.G., and McPhee S.J. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotion. Am J Med. 110 (2001) 551-557
11. Peppin J.F. An Engelhardtian analysis of interactions between pharmaceutical sales representatives and physicians. J Med Philos. 22 (1997) 623-641
12. Peppin J.F. Pharmaceutical sales representatives and physicians: ethical considerations of a relationship. J Med Philos. 21 (1996) 83-99
13. El Feki S. Prescription for change. Available at: http://economist.com/surveys/PrinterFriendly.cfm?Story_ID=4053970. Accessed August 21, 2005.
14. Lunn V. Some reflections on cooperation between physicians and the drug industry. Acta Psychiatr Scand. suppl 162 (1961) 13-17
15. Fassold R.W., and Gowdey C.W. A survey of physicians' reactions to drug promotion. CMAJ 98 (1968) 701-705
16. Linn L.S., and Davis M.S. Physicians' orientation toward the legitimacy of drug use and their preferred source of new drug information. Soc Sci Med 6 (1972) 199-203
17. Hemminki E. Review of literature on the factors affecting drug prescribing. Soc Sci Med. 9 (1975) 111-116
18. Smith M.C. Drug product advertising and prescribing: a review of the evidence. Am J Hosp Pharm. 34 (1977) 1208-1224
19. Rawlins M.D. Doctors and the drug makers. Lancet 2 (1984) 276-278
20. Lexchin J. Pharmaceutical promotion in Canada: convince them or confuse them. Int J Health Serv. 17 (1987) 77-89
21. Lexchin J. The medical profession and the pharmaceutical industry: an unhealthy alliance. Int J Health Serv. 18 (1988) 603-616
22. Lexchin J. Doctors and detailers: therapeutic education or pharmaceutical promotion?. Int J Health Serv. 19 (1989) 663-679
23. Freeman J.W., and Kaatz B. The physician and the pharmaceutical detail man: an ethical analysis. J Med Humanit Bioeth. 8 (1987) 34-39
24. Bricker E.M. Industrial marketing and medical ethics. N Engl J Med. 320 (1989) 1690-1692
25. Chren M.M., and Landefeld C.S. Physicians' behavior and their interaction with drug companies. JAMA 271 (1994) 684-689
26. Westfall J.M., McCabe J., and Nicholas R.A. Personal use of drug samples by physicians and office staff. JAMA. 278 (1997) 141-143
27. Morelli D., and Koenigsberg M.R. Sample medication dispensing in a residency practice. J Fam Pract. 34 (1992) 42-48
28. Pharmaceutical Research and Manufacturers of America. Code on interactions with healthcare professionals. Available at: http://www.phrma.org/publications/policy//2004-01-19.391.pdf. Accessed August 13, 2005.
29. Ziegler M.G., Lew P., and Singer B.C. The accuracy of drug information from pharmaceutical sales representatives. JAMA. 273 (1995) 1296-1298
30. Hensley S. Drug firms shown classroom door: continuing-ed programs for doctors aim to reduce influence of big companies. Wall Street Journal (2003) D5 January 14
31. Holmer A.F. Industry strongly supports continuing medical education. JAMA. 285 (2001) 2012-2014
32. Sweeney H.A. Pharma PR or medical education?. [letter]. Hastings Cent Rep. 35 (2005) 4
33. Wilson F.S. Continuing medical education: ethical collaboration between sponsor and industry. Clin Orthopaed Rel Res. 412 (2003) 33-37
34. Relman A.S. Separating continuing medical education from pharmaceutical marketing. JAMA. 285 (2001) 2009-2012
35. Elliott C. Pharma goes to the laundry: public relations and the business of medical education. Hastings Cent Rep. 34 (2004) 18-23
36. Healy D., and Cattell D. Interface between authorship, industry, and science in the domain of therapeutics. Br J Psychiat. 183 (2003) 22-27
37. Accreditation Council for Continuing Medical Education. Standards for commercial support. Available at: http://www.accme.org/dir_docs/doc_upload/68b2902a-fb73-44d1-8725-80a1504 e520c_uploaddocument.pdf. Accessed August 16, 2005..
38. Sorrell WH. Pharmaceutical marketing disclosures: report of Vermont Attorney General William H. Sorrell, May 10, 2005. Available at: http://www.atg.state.vt.us/upload/1115733046_Pharmaceutical_Marketing_Di sclosures_-_Report_of_Vermont_Attorney_General_William_H_Sorrell.pdf. Accessed August 17, 2005.
39. Moskop J.C. Looking a gift horse in the mouth?. emergency physicians and gifts from industry. ACEP News (2002) 5 June
40. Moskop J.C., and Birinyi F. Ethics and drug company gifts to physicians. APA Newsl Philos Med. 14 (1982) 1-2
41. Steinman M.A., Shlipak M.G., and McPhee S.J. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med. 110 (2001) 551-557
42. Guldal D., and Semin S. The influences of drug companies' advertising programs on physicians. Int J Health Serv. 30 (2000) 585-595
43. Roughead E.E., Harvey K.J., and Gilbert A.L. Commercial detailing techniques used by pharmaceutical representatives to influence prescribing. Aust N Z J Med. 28 (1998) 306-310
44. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift?. JAMA 283 (2000) 373-380
45. Chew L.D., O'Young D.S., Hazlet T.K., et al. A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med. 15 (2000) 478-483
46. Orlowski J.P., and Wateska L. Effects of pharmaceutical firm enticements on physician prescribing practices. Chest 102 (1992) 270-273
47. Dieperink M.E., and Drogemuller L. Industry-sponsored grand rounds and prescribing behavior. JAMA 285 (2001) 1443-1444
48. Spingon R.W., Berlin J.A., and Strom B.L. When pharmaceutical manufacturers' employees present grand rounds, what do residents remember?. Acad Med. 71 (1996) 86-88
49. Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns, and clerks. CMAJ 153 (1995) 553-559
50. Villaneuva P., Peiro S., Librero J., et al. Accuracy of pharmaceutical advertisements in medical journals. Lancet 361 (2003) 27-32
51. Wilkies M.S., Doblin B.H., and Shapiro M.F. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med. 116 (1992) 912-919
52. Stryer D., and Bero L.A. Characteristics of materials distributed by drug companies. J Gen Intern Med. 11 (1996) 575-583
53. Dana J., and Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA 290 (2003) 252-255
54. Stell L.K. Against the flow: why physicians should listen to drug reps. ASBH Exchange 8 (2005) 1 4-5
55. Mainous III A.G., Hueston W.J., and Rich E.D. Patient perceptions of physician acceptance of gifts from the pharmaceutical industry. Arch Fam Med. 4 (1995) 335-339
56. Gibbons R.V., Landry F.J., Bouch D.I., et al. A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts. J Gen Intern Med. 13 (1998) 151-154
57. American College of Physicians. Physicians and the pharmaceutical industry. Ann Intern Med. 112 (1990) 624-626
58. Council on Ethical and Judicial Affairs, American Medical Association. Gifts to physicians from industry. JAMA 265 (1991) 501
59. Randall T. AMA, pharmaceutical association form "solid front" on gift-giving guidelines. JAMA. 265 (1991) 2304-2305
60. Randall T. Kennedy hearings say no more free lunch-or much else-from drug firms. JAMA. 265 (1991) 440-442
61. Society for Academic Emergency Medicine. Emergency physicians and the biomedical industry. Available at: http://www.saem.org/download/industry.pdf. Accessed August 19, 2005.
62. American College of Emergency Physicians. Gifts to emergency physicians from the biomedical industry. Available at: http://www.acep.org/3,575,0.html. Accessed August 19, 2005.
63. Adams C. Doctors on the run can "dine 'n' dash" in style in New Orleans. Wall Street Journal (2001) A1 May 14
64. Studdert D.M., Mello M.M., and Brennan T.A. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry: self-regulation in the shadow of federal prosecution. N Engl J Med. 351 (2004) 1891-1900
65. American Medical Association. Ethical guidelines for gifts to physicians from industry. Available at: http://www.ama-assn.org/ama/pub/category/5689.html. Accessed August 19, 2005.
66. Romano M. Prescription for conflict. Mod Healthc. 31 (2001) 14
67. American Medical Student Association. AMSA's PharmFree campaign. http://www.amsa.org/prof/pharmfree.cfm. AAccessed August 19, 2005.
68. Office of Inspector General, Department of Health and Human Services. Compliance program guidance for pharmaceutical manufacturers. Fed Reg. 68 (2003) 23731-23743. http://oig.hhs.gov/authorities/docs/03/050503FRCPGPharmac.pdf Available at: http://oig.hhs.gov/authorities/docs/03/050503FRCPGPharmac.pdf. Accessed August 20, 2005
69. Keim S.M., Mays M.Z., and Grant D. Interactions between emergency medicine programs and the pharmaceutical industry. Acad Emerg Med 11 (2004) 19-26
70. Keim S., Perina D.G., and CORD Board of Directors. Council of Emergency Medicine Residency Directors position on interactions between emergency medicine residencies and the pharmaceutical industry. Acad Emerg Med. 11 (2004) 78